Nearly uniform failure of atrial flutter ablation and continuation of antiarrhythmic agents (hybrid therapy) for the long-term control of atrial fibrillation

1 New Oral Anticoagulants in Non-Valvular Atrial Fibrillation High Blood Pressure & Cardiovascular Prevention, May 13, 2013

2 Atrial fibrillation-induced cardiac troponin I release International Journal of Cardiology, April 29, 2013

3 Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial JACC - Journal of the American College of Cardiology, May 10, 2013

4 1:1 atrial-flutter. Prevalence and clinical characteristics International Journal of Cardiology, May 2, 2013

5 Atrial Fibrillation in Athletes International Journal of Sports Medicine, May 3, 2013

6 A Prospective Randomized Study Comparing Isolation of the Arrhythmogenic Vein Versus All Veins in Paroxysmal Atrial Fibrillation Clinical Cardiology, May 14, 2013

7 Risk of Stroke or Systemic Embolism in Atrial Fibrillation Patients Treated With Warfarin Stroke, April 23, 2013

8 New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: More Choices Bring More Challenges Hospital Pharmacy, May 8, 2013    Review Article

9 Effects of high dose intravenous fish oil on human atrial electrophysiology: Implications for possible anti- and pro-arrhythmic mechanisms in atrial fibrillation International Journal of Cardiology, April 25, 2013

10 Cost-Effectiveness of Dronedarone in Patients With Atrial Fibrillation in the ATHENA Trial Canadian Journal of Cardiology, April 29, 2013